Why Biogen's Alzheimer's drug Aduhelm is so controversial
January 04, 2022 at 11:55 AM EST
Biogen's Alzheimer's drug Aduhelm was heralded as a historic triumph against the memory-robbing disease. Now, the company is trying to keep it afloat.
